Thermo Fisher Scientific (NYSE: TMO) reported strong first-quarter results, with adjusted earnings per share (EPS) and revenue surpassing analysts’ estimates. The company’s revenue of $10.34 billion exceeded expectations of $10.16 billion, while adjusted EPS of $5.11 outperformed the estimate of $4.71. Despite a 3% revenue decline year-over-year, Thermo Fisher posted a 2% increase in adjusted EPS and a 4% growth in GAAP diluted EPS. Chairman and CEO Marc N. Casper attributed the success to the company’s growth strategy and PPI Business System, emphasizing customer success, commercial execution, and operational discipline. Thermo Fisher has raised its full-year guidance, expecting revenue between $42.3 billion and $43.3 billion and adjusted EPS between $21.14 and $22.02. The company’s proactive capital deployment included a $3.0 billion stock repurchase and an 11% dividend increase, reflecting its confidence in its financial strength and commitment to shareholder value.